Deep Learning for Histopathological Classification and Prognostication of Gynaecologic Smooth Muscle Tumours
- Conditions
- Stump
- Interventions
- Other: No intervention
- Registration Number
- NCT06540846
- Lead Sponsor
- Institut Bergonié
- Brief Summary
Smooth muscle tumors of the uterus that do not fit the diagnostic criteria of benignity (such as leiomyomas) or malignancy (such as leiomyosarcomas) are called STUMP (smooth muscle tumor of uncertain malignant potential). A potential solution to this problem could be the application of predictive models using artificial intelligence (AI) to aid in the histopathological classification and prognosis of gynecological smooth muscle tumors. Deep learning using convolutional neural networks represents a specific class of machine learning, in which predictive models are trained by considering small groups of pixels in digital images and iteratively identifying salient features. In this study, we aim to develop deep learning models capable of accurately subclassifying and predicting the prognosis of gynecological smooth muscle tumors, based on histopathological features of hematoxylin and eosin (H\&E) slides. The aim is to develop a diagnostic and prognostic algorithm to help pathologists better classify and diagnose uterine smooth muscle tumors and predict their clinical course.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 392
- Patients with a diagnosis of uterine smooth muscle tumors (leiomyomas, smooth muscle tumors of uncertain malignancy and leiomyosarcomas), registered in the RRePS database and/or treated at Institut Bergonié or one of the participating centers.
- Histopathological material available (kerosene blocks and/or slides).
- na
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description STUMP cohort No intervention Smooth muscle tumors of the uterus that do not fit the diagnostic criteria of benignity (such as leiomyomas) or malignancy (such as leiomyosarcomas) : smooth muscle tumor of uncertain malignant potential Leiomyoma-leiomyosarcoma No intervention Smooth muscle tumors of the uterus that do fit the diagnostic criteria of benignity (such as leiomyomas) or malignancy (such as leiomyosarcomas)
- Primary Outcome Measures
Name Time Method Develop deep learning models that can accurately subclassify gynaecologic smooth muscle tumours throughout the conduct of the study - an expected average of 6 months after data collection Develop deep learning based on digitalized slides
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Institut Bergonie
🇫🇷Bordeaux, France